Implications of the updated Lung CT Screening Reporting and Data System (Lung-RADS version 1.1) for lung cancer screening

Abstract

Lung cancer remains the leading cause of cancer death in the United States. Screening with low-dose computed tomography (LDCT) has been proven to aid in early detection of lung cancer and reduce disease specific mortality. In 2014, the American College of Radiology (ACR) released version 1.0 of the Lung CT Screening Reporting and Data System (Lung-RADS) as a quality tool to standardize the reporting of lung cancer screening LDCT. In 2019, 5 years after the implementation of Lung-RADS version 1.0 the ACR released the updated Lung-RADS version 1.1 which incorporates initial experience with lung cancer screening. In this review, we outline the implications of the changes and additions in Lung-RADS version 1.1 and examine relevant literature for many of the updates. We also highlight several challenges and opportunities as Lung-RADS version 1.1 is implemented in lung cancer screening programs.

Glioblastoma Surgery Imaging–Reporting and Data System: Validation and Performance of the Automated Segmentation Task

“…The automatic generation of standardized reports is bound to the same principles and requirements as the segmentation task, where robustness and repeatability are key. Standard Reporting And Data Systems (RADSs) have been proposed for several solid tumors, such as in prostate cancer [ 14 ], breast cancer [ 15 ], head and neck cancer [ 16 ], and lung cancer [ 17 ]. Common rules for imaging techniques, reports’ terminology, and definitions of tumor features and treatment response were defined.…”

Chụp Cắt Lớp Vi Tính Liều Thấp Bằng Công Cụ “Lung - Rads” Trong Tầm Soát Và Phát Hiện Sớm Ung Thư Phổi

“…Tháng 4 năm 2014, Hội đồng tầm soát ung thư phổi thuộc American College of Radiology (ACR) đã thiết lập hệ thống dữ liệu đánh giá về nốt mờ phổi LungRADS (Lung Imaging Reporting and Data System), phiên bản 1.0 nhằm mục đích đánh giá, phân loại nốt mờ phổi theo tính chất ác tính, đồng thời khuyến cáo khoảng thời gian theo dõi các nốt mờ bằng CLVT ngực liều thấp; đến năm 2019 đã cập nhật phiên bản 1.1. Tuy nhiên, Việt Nam vẫn đang sử dụng phổ biến phân loại năm 2014 [20], [21]. Nội dung áp dụng cụ thể theo bảng 3.…”

Incidental findings on lung cancer screening: pictorial essay and systematic checklist

“…Different communication strategies have been suggested for reporting IFs on LCS. The Lung CT Screening Reporting and Data System provides the S modifier for clinically significant or potentially clinically significant non-lung cancer findings 15 but does not specify which IFs should be reported or acted upon. The ESR and the European Respiratory Society (ERS) recommend that IFs that are clinically significant (i.e., with a major or adverse impact, or for which there is an established intervention that benefits the patient) and of general agreement (i.e., minimal interobserver variation) be reported and a recommendation for intervention be given.…”